Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 KO Manufacturing
Open in API
Filings indexed 553 across all filing types
Latest filing 2026-03-04 Major Shareholding Noti…
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Jin Yang-gon) and special related parties, including stock option grants and collateral agreements. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2026-03-04 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required when an entity's shareholding in a listed company crosses a specific threshold (typically 5%). This is a standard disclosure document filed with the Financial Supervisory Service (FSS) in South Korea, commonly referred to as a '5% report'. It details the identity of the shareholder (BlackRock), the target company (HLB Co., Ltd.), the purpose of holding (simple investment), and the specific changes in share ownership. This fits the 'Major Shareholding Notification' category.
2026-03-03 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from HLB regarding a significant change in financial structure (revenue or profit/loss exceeding 30%). It provides a summary of financial performance (revenue, operating profit, net income) comparing the current fiscal year to the previous year. This type of disclosure is a standard regulatory requirement for listed companies to announce preliminary financial results before the final audited annual report is published. It fits the definition of an Earnings Release (ER) as it provides key financial highlights and the reasons for the variance. FY 2025
2026-02-26 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to specific individuals, including the number of shares, exercise price, and vesting conditions. In the context of Korean corporate filings (DART system), this is a specific regulatory disclosure regarding capital changes and management incentives, which falls under the 'Regulatory Filings' (RNS) category as it is a mandatory disclosure of a corporate event that does not fit into the other specific categories like 'Director's Dealing' (which usually refers to market trades) or 'Share Issue' (which usually refers to public offerings).
2026-02-26 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집결의) for HLB. It details the date, location, agenda items (financial statement approval, director appointments, business purpose changes), and voting procedures. This document is a standard proxy solicitation material sent to shareholders to inform them of the upcoming meeting and request their votes, which fits the definition of a Proxy Solicitation & Information Statement (PSI).
2026-02-26 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Statement) and contains detailed information regarding the upcoming Annual General Meeting (AGM), including the meeting date, agenda items (approval of financial statements, election of directors, etc.), and instructions for electronic voting. While it contains some financial summary data, its primary purpose is to solicit proxies from shareholders for the AGM. According to the provided definitions, this falls under 'Proxy Solicitation & Information Statement'.
2026-02-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.